Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
Collegium Pharmaceutical plans to release its financial results for the first quarter of 2026 before market open on May 7, followed by a live conference call and webcast. The company highlights its focus on responsible pain management and neuropsychiatry, with JORNAY PM® as its lead growth product.